- Platform Technologies
Bioanalytical Mass Spectrometry for Proteome and Lipidome Analysis
The focus of the Reid group is on research to develop bioanalytical mass spectrometry and associated chemical and biochemical analysis strategies for proteome and lipidome characterization, and their application toward understanding the role of proteins (particularly those containing post translational modifications) and lipids in disease, including cancer, diabetes and diabetic complications.
Areas of Interest
- Analytical Chemistry - Biomolecular mass spectrometry
- Organic Chemistry - Novel probes for biomolecular structural characterisation
- Proteomics and Lipidomics - Post translational modification analysis/Lipid biomarkers of disease
Raised on a farm in Ararat in western Victoria, Gavin moved to Melbourne after completing high school in 1986. Since then, he has held a variety of scientific technical research and academic appointments in Australia and the USA. From 1987-1997 he was employed as a Research Assistant with Prof. Richard Simpson in the Joint Protein Sequencing Laboratory at the Ludwig Institute for Cancer Research in Melbourne, Australia, while studying part time to obtain an Associate Diploma in Applied Science (1990-1991). He then earned a Post Graduate Diploma in Science in 1997 and a PhD in Chemistry in 2000 from the University of Melbourne, under the joint supervision of Prof. Richard O’Hair and Prof. Simpson, then carried out post-doctoral research with Prof. Scott McLuckey at Purdue University, Indiana USA from 2002-2004. After initially establishing his independent research career in 2002 in Australia as an Assistant Member at the Ludwig Institute for Cancer Research, Gavin moved to Michigan State University, Michigan, USA in 2004 as an Assistant Professor, where he was promoted (early) to the rank of Associate Professor with tenure in 2009. He then returned to Australia to take up his current position in June 2014.
Gavin has over 20 years’ experience in the development of analytical biochemistry, mass spectrometry and associated chemical strategies for proteome and lipidome analysis, and their application toward understanding the role of proteins and lipids in disease, including cancer, diabetes and diabetic complications. To date, this interdisciplinary and highly collaborative research has resulted in 140 peer-reviewed publications, 3 patents, presentations at 77 national and international conferences, and 52 invited seminars. Over $7.8M has been raised in total funding to support this research, from agencies including the National Institutes of Health, the National Science Foundation, the Australian Research Council, the Multiple Myeloma Research Foundation, the Juvenile Diabetes Research Foundation, and multiple industry groups.